Abstract
Poly(ADP-ribose) polymerase-1 (PARP-1) is the guardian of the genome acting as a sentinel for genomic damage. However, PARP-1 is also mediator of cell death after ischemia-reperfusion injury, glutamate excitotoxicity, and various inflammatory processes. The biochemistry underlying PARP-1-mediated cell death has remained elusive, although NAD+ consumption and energy failure have been thought to be one of the possible molecular mechanisms. Recent observations link PARP-1 activation with translocation of apoptosis-inducing factor (AIF) to the nucleus and indicate that AIF is an essential downstream effector of PARP-1-mediated cell death. PARP-1 activation signals AIF release from the mitochondria, resulting in a novel, caspase-independent pathway of programmed cell death. These recent findings suggest that AIF maybe a target for development of future therapeutic treatment for many neurological disorders involving excitotoxicity.
Original language | English |
---|---|
Pages (from-to) | 303-317 |
Number of pages | 15 |
Journal | Neurobiology of Disease |
Volume | 14 |
Issue number | 3 |
DOIs | |
State | Published - Dec 2003 |
Bibliographical note
Funding Information:This work was supported by grants from the National Institutes of Health, the Robert Packard Center for ALS Research at Johns Hopkins Medical Institutions, the American Heart Association, and the Mary Lou McIlhaney Scholar Award.